These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

538 related items for PubMed ID: 31689123

  • 1. Long noncoding RNA MALAT1 participates in the pathological angiogenesis of diabetic retinopathy in an oxygen-induced retinopathy mouse model by sponging miR-203a-3p.
    Yu L, Fu J, Yu N, Wu Y, Han N.
    Can J Physiol Pharmacol; 2020 Apr; 98(4):219-227. PubMed ID: 31689123
    [Abstract] [Full Text] [Related]

  • 2. MiR-203a-3p inhibits retinal angiogenesis and alleviates proliferative diabetic retinopathy in oxygen-induced retinopathy (OIR) rat model via targeting VEGFA and HIF-1α.
    Han N, Xu H, Yu N, Wu Y, Yu L.
    Clin Exp Pharmacol Physiol; 2020 Jan; 47(1):85-94. PubMed ID: 31408201
    [Abstract] [Full Text] [Related]

  • 3. LncRNA-MALAT1 promotes neovascularization in diabetic retinopathy through regulating miR-125b/VE-cadherin axis.
    Liu P, Jia SB, Shi JM, Li WJ, Tang LS, Zhu XH, Tong P.
    Biosci Rep; 2019 May 31; 39(5):. PubMed ID: 30988072
    [Abstract] [Full Text] [Related]

  • 4. YAP1 is required for the angiogenesis in retinal microvascular endothelial cells via the inhibition of MALAT1-mediated miR-200b-3p in high glucose-induced diabetic retinopathy.
    Han N, Tian W, Yu N, Yu L.
    J Cell Physiol; 2020 Feb 31; 235(2):1309-1320. PubMed ID: 31313295
    [Abstract] [Full Text] [Related]

  • 5. MicroRNA-199a-3p inhibits angiogenesis by targeting the VEGF/PI3K/AKT signalling pathway in an in vitro model of diabetic retinopathy.
    Wang L, Liu WX, Huang XG.
    Exp Mol Pathol; 2020 Oct 31; 116():104488. PubMed ID: 32622012
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Competing endogenous RNA network associated with oxygen-induced retinopathy: Expression of the network and identification of the MALAT1/miR-124-3p/EGR1 regulatory axis.
    Xia F, Xu Y, Zhang X, Lyu J, Zhao P.
    Exp Cell Res; 2021 Nov 01; 408(1):112783. PubMed ID: 34469714
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. MicroRNA-384-3p inhibits retinal neovascularization through targeting hexokinase 2 in mice with diabetic retinopathy.
    Xia F, Sun JJ, Jiang YQ, Li CF.
    J Cell Physiol; 2018 Jan 01; 234(1):721-730. PubMed ID: 30191948
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. MSC-derived exosomal lncRNA SNHG7 suppresses endothelial-mesenchymal transition and tube formation in diabetic retinopathy via miR-34a-5p/XBP1 axis.
    Cao X, Xue LD, Di Y, Li T, Tian YJ, Song Y.
    Life Sci; 2021 May 01; 272():119232. PubMed ID: 33600866
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.